Netta Blondheim-Shraga

Company: Brainstorm Cell Therapeutics

Job title: Senior Vice President, Research & Development

Seminars:

Evaluating Multimodal Effects of Debamestrocel on Varying CSF Biomarker Pathways in ALS Linked to Clinical Outcomes 10:30 am

Showcasing the potential multimodal mechanism of action of Debamestrocel through analysis of 45 biomarkers by two subgroups characterized by ALS-FRS-R into a panel approach, to build a clearer and more holistic picture of disease progression and Debamestrocel efficacy on the complex and heterogenous pathology within ALS Reviewing the clinical utility of NfL and NfH as…Read more

day: Conference Day One Track B